Vol. 31.Issue. 1. January - February 2012 | Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)

ISSN: 2253-8089

The Revista Española de Medicina Nuclear e Imagen Molecular (Spanish Journal of Nuclear Medicine and Molecular Imaging), was founded in 1982, and is the official journal of the Spanish Society of Nuclear Medicine and Molecular Imaging, which has more than 700 members. The Journal, which publishes 6 regular issues per year, has the promotion of research and continuing education in all fields of Nuclear Medicine as its main aim. For this, its principal sections are Originals, Clinical Notes, Images of Interest, and Special Collaboration articles. The works may be submitted in Spanish or English and are subjected to a peer review process. In 2009, it became the leading Spanish journal in the field of Medical Imaging on having an Impact Factor , awarded by the Journal Citation Reports.

See more Open Access Option

Indexed in:

Science Citation Index Expander, Medline, IME, Bibliomed, EMBASE/Excerpta Medica, Healthstar, Cancerlit, Toxine, Inside Conferences, Scopus

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2022

1.2

Citescore

CiteScore measures average citations received per document published.

Citescore 2022

1.2

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2022

0.254

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2022

0.414

View more metrics

Journal Information

Previous Issue | Next Issue

Issue

Vol. 31. Issue 1.

Pages 1-58 (January - February 2012)

Editorial

News from The Spanish Journal of Nuclear Medicine and Molecular Imaging

I. Banzo, J.C. Alonso-Farto, C. de la Fuente, M. Mitjavila, A. Serena

Rev Esp Med Nucl Imagen Mol. 2012;31:1-2

Original articles

The Role of FDG-PET/CT in Ovarian Cancer Patients with High Tumor Markers or Suspicious Lesion on Contrast-Enhanced CT in Evaluation of Recurrence and/or in Determination of Intraabdominal Metastases

O. Sari, B. Kaya, P. Ozcan Kara, G. Kara Gedik, C. Celik, O. Ozbek, M. Serdengecti

Rev Esp Med Nucl Imagen Mol. 2012;31:3-8

99mTc-HMPAO labelled white blood cell scintigraphy in the diagnosis and monitoring of response of the therapy in patients with active bronchiectasis

G. Altıay, T.F. Çermik

Rev Esp Med Nucl Imagen Mol. 2012;31:9-14

Clinical Relevance of Incidental Finding of Focal Uptakes in the Colon during 18F-FDG PET/CT Studies in Oncology Patients without Known Colorectal Carcinoma and Evaluation of the Impact on Management

G. Salazar Andía, A. Prieto Soriano, A. Ortega Candil, M.N. Cabrera Martín, C. González Roiz, J.J. Ortiz Zapata, J. Cardona Arboniés, L. Lapeña Gutiérrez, J.L. Carreras Delgado

Rev Esp Med Nucl Imagen Mol. 2012;31:15-21

18F-FDG-PET/CT in the surveillance of patients with lymphoma: Detection of asymptomatic recurrences

A.M. García Vicente, M. Bellón Guardia, A. Soriano Castrejón, C. Calle Primo, J.M. Cordero García, A. Palomar Muñoz, J.P. Pilkington Woll, M.P. Talavera Rubio, B. Hernández Ruiz

Rev Esp Med Nucl Imagen Mol. 2012;31:22-7

Clinical notes

Coexistence of Two Different Types of Lymphoma in a Patient with Sjögren's Syndrome. The Usefulness of the PET-CT

J.R. Infante De La Torre, C. Durán Barquero, L. García Bernardo, J. Groiss, J.I. Rayo Madrid, J. Serrano Vicente, M.L. Domínguez Grande, R. Sánchez Sánchez

Rev Esp Med Nucl Imagen Mol. 2012;31:28-30